Literature DB >> 8584485

Enhanced intestinal absorption of oxytocin peptide analogues in the absence of pancreatic juice in pigs.

D P Lundin1, S Lundin, H Olsson, B W Karlsson, B R Weström, S G Pierzynowski.   

Abstract

PURPOSE: The present investigation was done to study the intestinal absorption of three oxytocin peptide analogues and to elucidate the role of pancreatic juice on their absorption.
METHODS: In conscious chronically catheterized pigs (6-8 weeks of age) plasma concentration of the peptides, [Mpa, D-Tyr(Ethyl), Thr, Orn]-oxytocin (F314), [Mpa, D-Tyr(Ethyl), Val, D-Arg]-oxytocin (CAT), and [Mpa, D-Tyr(Ethyl), Thr, Orn, desGly, carba]-oxytocin (F327) after intraduodenal administration, during presence or diversion of the pancreatic juice via a pancreatic duct catheter, were determined by radioimmunoassay. The stability of the peptides to degradation was determined in vitro by incubation with activated pancreatic juice, chymotrypsin or trypsin, followed by reversed phase HPLC analyses.
RESULTS: All peptides were absorbed with a bioavailability of about 0.5% in the presence of pancreatic juice, but increased to 1.0%, 2.1%, and 13.5% for F314, CAT, and F327, respectively, when the pancreatic juice was diverted from the intestine. After incubation with pancreatic juice 95% of F314, 98% of F327, and 100% of CAT was found intact. When incubated with trypsin CAT remained intact while F314 and F327 were degraded by 54% and 46%, respectively. Incubation with purified chymotrypsin did not degrade the test peptides.
CONCLUSIONS: The results indicate that the increased absorption of peptides observed under conditions of diverted pancreatic juice cannot only be explained by the absence of pancreatic enzymes, but also by changed absorptive properties in the gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8584485     DOI: 10.1023/a:1016283320527

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

1.  Biliary excretion of the vasopressin analogue DDAVP after intraduodenal, intrajugular and intraportal administration in the conscious pig.

Authors:  S Lundin; S G Pierzynovski; B R Weström; H I Bengtsson
Journal:  Pharmacol Toxicol       Date:  1991-03

2.  Desolvation energy: a major determinant of absorption, but not clearance, of peptides in rats.

Authors:  M S Karls; B D Rush; K F Wilkinson; T J Vidmar; P S Burton; M J Ruwart
Journal:  Pharm Res       Date:  1991-12       Impact factor: 4.200

3.  An oligopeptide permeates intestinal tight junctions at glucose-elicited dilatations. Implications for oligopeptide absorption.

Authors:  K Atisook; J L Madara
Journal:  Gastroenterology       Date:  1991-03       Impact factor: 22.682

4.  Absorption of intragastrically administered DDAVP in conscious dogs.

Authors:  S Lundin; H Vilhardt
Journal:  Life Sci       Date:  1986-02-24       Impact factor: 5.037

5.  Antidiuretic response in conscious dogs following peroral administration of arginine vasopressin and its analogues.

Authors:  H Vilhardt; P Bie
Journal:  Eur J Pharmacol       Date:  1983-09-30       Impact factor: 4.432

6.  Expression cloning of a mammalian proton-coupled oligopeptide transporter.

Authors:  Y J Fei; Y Kanai; S Nussberger; V Ganapathy; F H Leibach; M F Romero; S K Singh; W F Boron; M A Hediger
Journal:  Nature       Date:  1994-04-07       Impact factor: 49.962

7.  Biological half-life and organ distribution of [3H]8-arginine-vasopressin in the rat.

Authors:  T Janáky; F A László; F Sirokmán; J L Morgat
Journal:  J Endocrinol       Date:  1982-06       Impact factor: 4.286

8.  Effect of dietary amino acids, casein, and soybean trypsin inhibitor on pancreatic protein secretion in rats.

Authors:  B O Schneeman; I Chang; L B Smith; R L Lyman
Journal:  J Nutr       Date:  1977-02       Impact factor: 4.798

9.  Development of exocrine pancreas function in chronically cannulated pigs during 1-13 weeks of postnatal life.

Authors:  S G Pierzynowski; B R Weström; J Svendsen; B W Karlsson
Journal:  J Pediatr Gastroenterol Nutr       Date:  1990-02       Impact factor: 2.839

10.  Resistance of 1-deamino-[8-D-arginine]-vasopressin to in vitro degradation as compared with arginine vasopressin.

Authors:  K Matsui; T Kimura; K Ota; K Iitake; M Shoji; M Inoue; K Yoshinaga
Journal:  Endocrinol Jpn       Date:  1985-08
View more
  3 in total

1.  Inhibition of binding of an enzymatically stable thrombin inhibitor to lumenal proteases as an additional mechanism of intestinal absorption enhancement.

Authors:  M Sjöström; L Lindfors; A L Ungell
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

2.  Associations Between Nurse-Guided Variables and Plasma Oxytocin Trajectories in Premature Infants During Initial Hospitalization.

Authors:  Ashley Weber; Tondi M Harrison; Loraine Sinnott; Abigail Shoben; Deborah Steward
Journal:  Adv Neonatal Care       Date:  2018-02       Impact factor: 1.968

3.  Effect of oxytocin injection to milching buffaloes on its content & stability in milk.

Authors:  Raghu Pullakhandam; Ravindranadh Palika; Sudershan Rao Vemula; Kalpagam Polasa; Sesikeran Boindala
Journal:  Indian J Med Res       Date:  2014-06       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.